People with Crohn’s disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, according to a new study by Weill Cornell Medicine researchers.
The gift from philanthropist Tom Secunda, co-founder of Bloomberg L.P., will help fund artificial intelligence-related research at Cornell Tech in New York City and at the Cornell Ann S. Bowers College of Computing and Information Science in Ithaca.
A new study has unveiled a precise picture of how an ion channel found in most mammalian cells regulates its own function with a “ball-and-chain” channel-plugging mechanism, according to investigators at Weill Cornell Medicine.
A new AI-based system for analyzing images taken over time can accurately detect changes and predict outcomes, which may be useful across a wide range of medical and scientific applications.
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.
A multinational, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
Weill Cornell Medicine researchers have found that intracranial hemorrhages, or “brain bleeds” caused by a ruptured blood vessel in the brain, doubles a person’s risk of developing dementia later in life.
Weill Cornell Medicine physician-scientists Dr. Niroshana Anandasabapathy and Dr. Rohit Chandwani have been elected members of the American Society for Clinical Investigation for 2025.
